An observational study of the securement of central venous access devices with a subcutaneous anchor device in a paediatric population at a tertiary level hospital. Issue 6 (November 2020)

• Record Type: Journal Article
• Authors: Fitzsimons, Kathryn Marie; Speekman, Joseph; Senior, Temora; Curtis, Kerrie; Cochrane-Davis, Alex; Barnes, Richard
• Is Part Of: Journal of vascular access. Volume 21:Issue 6(2020)
• Page Start: 959
• Page End: 962
• Publication Date: 2020-11
• Subjects: Vascular access -- securAcath -- CVAD -- subcutaneous anchor -- paediatric catheters; Arterial catheterization -- Periodicals; Intravenous catheterization -- Periodicals; 612.13
• DOI: 10.1177/1129729820918460
• Languages: English
• ISSNs: 1129-7298

Abstract

Paediatric central venous access devices are associated with significant complications. Failure rates have been estimated to be as high as 25%, with securement failure a significant contributing factor. In this study, we evaluate the use of a subcutaneous securement device, securAcath TM, in minimising rates of central venous access device dislodgement and unintended early removal within a paediatric population. Data were collected on 52 consecutive paediatric patients, aged less than 18 years old, who required peripherally inserted central catheters and non-cuffed tunnelled centrally inserted central catheters. We found that the rate of securement failure with securAcath TM was 2.01 per 1000 catheter days. This compared to 2.58 in our previous practice without securAcath TM . With the use of securAcath TM, no securement failures were observed in our patients with non-cuffed tunnelled centrally inserted central catheters. There were three instances of securement failure in patients with peripherally inserted central catheters. We conclude that the use of a securAcath TM fixation device in central venous access devices is an effective method of securement, especially in use with non-cuffed tunneled centrally inserted central catheters. However, when significant tension is applied to the central venous access devices migration is still possible.